Kate has spent time learning the drug development industry from many different perspectives from lab to insights. She combines this with the unique philosophy of a patient with a chronic severe condition, namely asthma, to all her projects in an effort to provide the greatest value to clients.

Kate earned a Ph.D. in Pharmacology from the University of North Carolina at Chapel Hill, followed by a Howard Hughes post-doctoral fellowship at Stanford University. She then wanted a more commercial approach to the application of pharmacology and decided to join a consulting/market research firm, Frost & Sullivan where she was part of the first dedicated consulting group focused exclusively on the health sciences. She led projects on numerous topics including out-licensing genetic testing methodologies, rebranding NSAID products and tracking market dynamics of hemophilia products.

She subsequently moved into industry. After 5 years in the business insights group focusing on biologics at MedImmune/Astra Zeneca, she decided to rejoin consulting by linking up with some of her favourite consultants, groupH.

When she’s not working, Kate enjoys spending time in the great outdoors, usually in the company of her 2 Belgian Shepherds. They are great companions and subjects for another of her greatest passions – training animals. Though, she suspects that they are as effective at training her as she is at training them.